Feed Preview

Fast Growing

Muscular Dystrophy

Muscular Dystrophy diagram by Designua, Shutterstock
Designua, Shutterstock

Muscular dystrophy refers to a range of muscle diseases caused by defects in muscle proteins, leading to death of the muscle cells, with loss of muscle tissue, and weakness. Here are the latest discoveries pertaining to this disease.

Top 20 most recent papers
31
4
1
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Psychosocial impact of sport activity in neuromuscular disorders

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyApril 5, 2020
Gian Luca VitaGiuseppe Vita
1
Journal of Managed Care & Specialty Pharmacy

The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy

Journal of Managed Care & Specialty PharmacyApril 1, 2020
Foluso AgboolaSteven D Pearson
Circulation. Heart Failure

Keeping an Open Mind: Heart Transplant in Patients With Muscular Dystrophy

Circulation. Heart FailureMarch 29, 2020
Yasbanoo Moayedi, Heather J Ross
2
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

Congenital myasthenic syndrome due to DOK7 mutation in a cohort of patients with 'unexplained' limb-girdle muscular weakness

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of AustralasiaApril 3, 2020
Paulo José LorenzoniRosana Herminia Scola
Journal of Movement Disorders

Future of Tanscranial Magnetic Stimulation in Movement Disorders: Introduction of Novel Methods

Journal of Movement DisordersApril 4, 2020
Yoshikazu UgawaYasuo Terao
Pflügers Archiv : European journal of physiology

Skeletal muscle CaV 1.1 channelopathies

Pflügers Archiv : European journal of physiologyMarch 31, 2020
Bernhard E Flucher
Yonsei Medical Journal

Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy

Yonsei Medical JournalApril 2, 2020
Qing Li
Journal of Managed Care & Specialty Pharmacy

Evaluating a Stone of Hope: ICER's 2019 Review of Treatments for Duchenne Muscular Dystrophy

Journal of Managed Care & Specialty PharmacyApril 1, 2020
John Frederick Brandsema
Rinshō shinkeigaku = Clinical neurology

Severe ketoacidosis induced by short-term starvation in a patient with spinal muscular atrophy

Rinshō shinkeigaku = Clinical neurologyApril 3, 2020
Ryoma InuiNobuo Kohara

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/muscular-dystrophy/fa761a7d-daf6-4117-8a89-e2d1aae1ab5d